Gyeonggi-do, South Korea

Byoung Jun Kim

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Seoul National University. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Byoung Jun Kim. Retrieved from https://idiyas.com/inventor/byoung-jun-kim-d22wuzcf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Byoung Jun Kim: Innovator in Vaccine Development

Introduction

Byoung Jun Kim is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of vaccine development, particularly in the fight against tuberculosis. With a total of 2 patents to his name, Kim's work is recognized for its innovative approach and potential impact on public health.

Latest Patents

Kim's latest patents include a "Vaccine Composition for Preventing Tuberculosis Comprising Chorismate Mutase" and an "Immune Adjuvant Comprising Hepatitis B Virus-Derived Polypeptide." These inventions showcase his commitment to advancing medical science and improving vaccine efficacy.

Career Highlights

Currently, Byoung Jun Kim is affiliated with Seoul National University, where he continues to engage in groundbreaking research. His work at this esteemed institution allows him to collaborate with other leading scientists and contribute to the academic community.

Collaborations

Kim has worked alongside notable colleagues, including Hye in Jeong and Bum Joon Kim. These collaborations enhance the quality and scope of his research, fostering an environment of innovation and discovery.

Conclusion

Byoung Jun Kim is a dedicated inventor whose work in vaccine development is paving the way for advancements in public health. His contributions are vital in the ongoing battle against infectious diseases, and his innovative spirit continues to inspire future research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…